(Q44825735)

English

Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma

scientific article published in September 1989

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma (English)

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

0 references

1 reference

based on heuristic

inferred from title

author name string

C M Kim

1

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

W S Hong

2

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

J O Lee

3

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

T W Kang

4

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

Y W Kim

5

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

J K Song

6

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

T K Yun

7

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

C Y Kim

8

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 1989

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

80

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

9

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

904-909

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

Purification and physico-chemical characterization of rabbit tumor necrosis factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Drugs five years later. Cisplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Alfa interferon: combinations with other antineoplastic modalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Cellular receptor for 125I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Future perspectives for biological response modifiers: a viewpoint

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Biologic response modifiers as adjuncts to other therapeutic modalities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Stimulation of RNA Synthesis in L-929 Cells by Rabbit Tumor Necrosis Factor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

30 June 2018

Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5917856

15 August 2018

Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro antitumor effect of recombinant human tumor necrotizing factor on cultured human cancer cell lines and freshly isolated lung cancer cells by the human tumor clonogenic assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of actinomycin D- and cis-diamminedichloroplatinum(II)-induced killing of human fibroblasts by human beta-interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Colony inhibitory effect of recombinant human tumor necrosis factor (rH-TNF) and/or recombinant human interferon (rH-IFN)-alpha, -beta and -gamma on human lung cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effect of human recombinant interferon-gamma alone and in combination with adriamycin on a human colon cancer cell line (RPMI 4788) in vitro and in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro synergistic effects of natural human tumor necrosis factor and natural human interferon-alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/2513306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.1989.TB01733.X

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

29 June 2018

http://europepmc.org/abstract/PMC/5917856

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44825735&oldid=2047927368"